In the exciting climax of this miniseries, a vaccine is ready to issue to the world. But will this improve presidential popularity ratings.
A federal agent tries to turn a Genyologen employee into an asset.
An undercover scientist anticipates inoculation as evidence of a coverup but it turns out to be something different.
In an attempt to become a spy, Ray is in the middle of an interview at a major pharmaceutical competitor.
The government recruits a scientist to go undercover as a spy to gather information about a serum to cure the rampant disease.
The largest pharma-tech company weighs the advantages of a consortium to battle a global health crisis.
A major entity within the pharmaceutical consortium discusses ramifications of the Presidents’s international speech.
Premiere: In the year 2092, this world teeters on the edge of a new millennium or human extinction. But commercial and political tensions collide as solutions become manifest.
Featured authors and reviewers
This information does not constitute professional medical care or legal advice. Discuss personal concerns with your doctor or legal advisor.